-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Maintains Overweight on Edwards Lifesciences, Raises Price Target to $83

Benzinga·05/13/2025 16:01:14
Listen to the news
Piper Sandler analyst Adam Maeder maintains Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $80 to $83.